Perfect Optronics Sees Decrease in Revenue of Group for FY2024
THOMSON REUTERS03-11
Perfect Optronics Sees Decrease in Revenue of Group for FY2024
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
抱歉,当前请求异常(-1)
Medpace Holdings Inc - Amendment No. 7 Extends Revolving Credit Note to March 31, 2026 - SEC Filing
Medpace Holdings - Co Units Entered Amendment No. 7 to Loan Documents With PNC Bank - SEC Filing
Adverum Biotechnologies Inc - Company Expects to Report at Least One Material Weakness - SEC Filing
Adverum Biotechnologies Inc - Some Prior Financial Statements Should No Longer Be Relied Upon - SEC Filing
Repare Therapeutics: Lloyd M. Segal Resigned as President, CEO and Director
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial